Pancreatic Cancer Research

ResearcherUniversity of AntwerpNo recent work listed

Andreas Domen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1398-3061; OpenAlex author ID A5028808902. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer. Co-author DOI 10.1038/s41698-023-00480-y↗
  2. Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. Co-author DOI 10.3390/cancers13050987↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christophe Deben · 2 shared papers, 2021–2023 · strength 0.26
  2. Hans Prenen · 2 shared papers, 2021–2023 · strength 0.26
  3. Evelien Smits · 2 shared papers, 2021–2023 · strength 0.26
  4. Geert Roeyen · 2 shared papers, 2021–2023 · strength 0.26
  5. Timon Vandamme · 2 shared papers, 2021–2023 · strength 0.26
  6. Marc Peeters · 2 shared papers, 2021–2023 · strength 0.26
  7. Sofía L. J. Peeters · 1 shared paper, 2023 · strength 0.15
  8. Maxim Le Compte · 1 shared paper, 2023 · strength 0.15
  9. Delphine Quatannens · 1 shared paper, 2021 · strength 0.11
  10. Jonas R.M. Van Audenaerde · 1 shared paper, 2021 · strength 0.11
  11. Sara R. Zanivan · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.